[Federal Register Volume 66, Number 18 (Friday, January 26, 2001)]
[Notices]
[Pages 7923-7924]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-2337]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Centers Review Committee.
    Date: February 20, 2001.
    Time: 8:30 am to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Health Services Research Subcommittee.
    Date: February 28-March 1, 2001.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites & Chevy Chase Pavilion, 4300 Military 
Road, NW., Wisconsin at Western Avenue, Washington, DC 20015.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Treatment Research Subcommittee.
    Date: February 28, 2001.
    Time: 10 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Kesinee Nimit, Md, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse,

[[Page 7924]]

National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Treatment Research.
    Date: February 28, 2001.
    Time: 12:30 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, N.W., Wisconsin Ave. and Western Ave., Washington, DC 20015.
    Contact Person: Mark R. Green, PhD, Chief, CEASRB, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, Suite 3158, 6001 Executive Boulevard, 
Bethesda, MD 20892-9547, (301) 435-1431.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: March 6-8, 2001.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Medication Development Research Subcommittee.
    Date: March 7, 2001.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Chevy Chase Holiday Inn, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: January 17, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-2337 Filed 1-25-01; 8:45 am]
BILLING CODE 4140-01-M